SCHEMBL18178759

SCHEMBL18178759

CCC(=O)Oc1cccc(Cl)c1COc1cc(C)c(C)cc1CC

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGER1 P34995 2/20 0.39
PTGER4 P35408 2/20 0.39
PTGER3 P43115 2/20 0.39
PTGER2 P43116 2/20 0.39
MRGPRX4 Q96LA9 2/20 0.39
NPC1 O15118 2/20 0.38
KMT2A Q03164 3/20 0.38
ACHE P22303 1/20 0.38
ALDH1A1 P00352 1/20 0.38
HPGD P15428 2/20 0.36
KDM4E B2RXH2 1/20 0.36
LMNA P02545 1/20 0.36
GLA P06280 1/20 0.36
GAA P10253 1/20 0.36
MAPK1 P28482 1/20 0.36
HSD17B10 Q99714 1/20 0.36
FFAR1 O14842 1/20 0.36
FFAR4 Q5NUL3 1/20 0.36
MEN1 O00255 1/20 0.36
MITF O75030 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18182846 0.94 PTGER1 (0.38) PTGER1PTGER4PTGER3PTGER2MRGPRX4
SCHEMBL18530987 0.94 PTGER1 (0.38) PTGER1PTGER4PTGER3PTGER2MRGPRX4
SCHEMBL18182862 0.92 PTGER1 (0.38) PTGER1PTGER4PTGER3PTGER2MRGPRX4
SCHEMBL18178587 0.91 ALDH1A1 (0.38) PTGER1PTGER4PTGER3PTGER2MRGPRX4
SCHEMBL18178719 0.90 KMT2A (0.41) PTGER1PTGER4PTGER3PTGER2MRGPRX4
SCHEMBL18178750 0.90 MRGPRX4 (0.40) PTGER1PTGER4PTGER3PTGER2MRGPRX4
SCHEMBL18182028 0.89 KMT2A (0.39) PTGER1PTGER4PTGER3PTGER2MRGPRX4
SCHEMBL18532840 0.89 MAPT (0.38) PTGER1PTGER4PTGER3PTGER2MRGPRX4
SCHEMBL18178385 0.89 FABP4 (0.39) PTGER1PTGER4PTGER3PTGER2MRGPRX4
SCHEMBL18156516 0.89 PTGER1 (0.39) PTGER1PTGER4PTGER3PTGER2MRGPRX4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9573904-B2 Aromatic compound and use thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-02-21 US disclosed
US-20160311775-A1 AROMATIC COMPOUND AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2016-10-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160311775-A1 AROMATIC COMPOUND AND USE THEREOF ZCCHC8, CBR3, CBX8 PTGER1 4234/4885PTGER4 3370/4885PTGER3 3762/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.